Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clemons

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
Journal of Proteomics|January 3, 2014
Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuniKyoung-Soon Jang, Michael J Sweredoski, Robert L J Graham, et al.
Clinical & Experimental Metastasis|March 7, 2009
Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastasesE Amir, C Whyne, O C Freedman, et al.
Bioorganic Chemistry|December 25, 2025
New Insights of Muraymycin A1 and Its Analogs as DPAGT1 InhibitorsKatsuhiko Mitachi, Deidre Daria, Jacob M Kirsh, et al.
Nature Structural & Molecular Biology|July 19, 2022
Structurally derived universal mechanism for the catalytic cycle of the tail-anchored targeting factor Get3Michelle Y Fry, Vladimíra Najdrová, Ailiena O Maggiolo, et al.
Methodsx|November 1, 2019
A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studiesKatsuhiko Mitachi, Shou M Kurosu, Cody D Gillman, et al.
Journal of Bone Oncology|December 6, 2017
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancerJ F Hilton, M Clemons, G Pond, et al.
Journal of Surgical Oncology|May 13, 2010
Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?F C Wright, J Zubovits, S Gardner, et al.
Elife|January 16, 2014
USP13 antagonizes gp78 to maintain functionality of a chaperone in ER-associated degradationYanfen Liu, Nia Soetandyo, Jin-Gu Lee, et al.
Nature|February 25, 2026
Convergent MurJ flippase inhibition by phage lysis proteinsYancheng E Li, S Francesca Antillon, Grace F Baron, et al.
Current Oncology (Toronto, Ont.)|October 8, 2011
Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physiciansR Heisey, M Clemons, L Granek, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
Journal of Proteomics|January 3, 2014
Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuniKyoung-Soon Jang, Michael J Sweredoski, Robert L J Graham, et al.
Clinical & Experimental Metastasis|March 7, 2009
Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastasesE Amir, C Whyne, O C Freedman, et al.
Bioorganic Chemistry|December 25, 2025
New Insights of Muraymycin A1 and Its Analogs as DPAGT1 InhibitorsKatsuhiko Mitachi, Deidre Daria, Jacob M Kirsh, et al.
Nature Structural & Molecular Biology|July 19, 2022
Structurally derived universal mechanism for the catalytic cycle of the tail-anchored targeting factor Get3Michelle Y Fry, Vladimíra Najdrová, Ailiena O Maggiolo, et al.
Methodsx|November 1, 2019
A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studiesKatsuhiko Mitachi, Shou M Kurosu, Cody D Gillman, et al.
Journal of Bone Oncology|December 6, 2017
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancerJ F Hilton, M Clemons, G Pond, et al.
Journal of Surgical Oncology|May 13, 2010
Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?F C Wright, J Zubovits, S Gardner, et al.
Elife|January 16, 2014
USP13 antagonizes gp78 to maintain functionality of a chaperone in ER-associated degradationYanfen Liu, Nia Soetandyo, Jin-Gu Lee, et al.
Nature|February 25, 2026
Convergent MurJ flippase inhibition by phage lysis proteinsYancheng E Li, S Francesca Antillon, Grace F Baron, et al.
Current Oncology (Toronto, Ont.)|October 8, 2011
Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physiciansR Heisey, M Clemons, L Granek, et al.
Pageof 19